InvestorsHub Logo

wrinklesobw

10/13/21 10:23 AM

#141527 RE: dekeferrell #141524

I saw a fda approval a few years back that allowed them move to phase 3 testing it went from $2 to almost $30 settled back down around $8-$10 dollars a share.



It was for a pill. Don’t remember what it was for though or the company.